Virlogeux, V., Pradat, P., Hartig‐Lavie, K., Bailly, F., Maynard, M., Ouziel, G., Poinsot, D., Lebossé, F., Ecochard, M., Radenne, S., Benmakhlouf, S., Koffi, J., Lack, P., Scholtes, C., Uhres, A., Ducerf, C., Mabrut, J., Rode, A., Levrero, M., Combet, C., Merle, P., & Zoulim, F. (2017). direct‐acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C. Liver international, 37, 1122–1127. http://access.bl.uk/ark:/81055/vdc_100047830903.0x000011